ATE343572T1 - Benzimidazole und benzothiazole als inhibitoren der map-kinase - Google Patents
Benzimidazole und benzothiazole als inhibitoren der map-kinaseInfo
- Publication number
- ATE343572T1 ATE343572T1 AT03784749T AT03784749T ATE343572T1 AT E343572 T1 ATE343572 T1 AT E343572T1 AT 03784749 T AT03784749 T AT 03784749T AT 03784749 T AT03784749 T AT 03784749T AT E343572 T1 ATE343572 T1 AT E343572T1
- Authority
- AT
- Austria
- Prior art keywords
- benzothiazoles
- benzimidazoles
- kinase inhibitors
- map kinase
- map
- Prior art date
Links
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02380178 | 2002-08-09 | ||
| US42193902P | 2002-10-28 | 2002-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE343572T1 true ATE343572T1 (de) | 2006-11-15 |
Family
ID=31716856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03784749T ATE343572T1 (de) | 2002-08-09 | 2003-07-31 | Benzimidazole und benzothiazole als inhibitoren der map-kinase |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7320995B2 (de) |
| EP (1) | EP1554272B1 (de) |
| AR (1) | AR040770A1 (de) |
| AT (1) | ATE343572T1 (de) |
| AU (1) | AU2003256297A1 (de) |
| DE (1) | DE60309342T2 (de) |
| ES (1) | ES2274302T3 (de) |
| TW (1) | TW200404799A (de) |
| WO (1) | WO2004014900A1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060063065A1 (en) * | 2001-08-10 | 2006-03-23 | Clarke Robert L | Battery with bifunctional electrolyte |
| WO2005080380A1 (en) * | 2004-02-03 | 2005-09-01 | Eli Lilly And Company | Kinase inhibitors |
| MXPA06011021A (es) * | 2004-03-25 | 2007-04-13 | Johnson & Johnson | Compuestos de imidazol. |
| TW200639163A (en) * | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
| US7473784B2 (en) * | 2005-08-01 | 2009-01-06 | Bristol-Myers Squibb Company | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| ES2301380B1 (es) | 2006-08-09 | 2009-06-08 | Laboratorios Almirall S.A. | Nuevos derivados de 1,7-naftiridina. |
| MX2009003650A (es) * | 2006-10-06 | 2009-04-22 | Abbott Lab | Nuevos imidazotiazoles e imidazoxazoles. |
| ES2320955B1 (es) | 2007-03-02 | 2010-03-16 | Laboratorios Almirall S.A. | Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida. |
| ES2329639B1 (es) | 2007-04-26 | 2010-09-23 | Laboratorios Almirall S.A. | Nuevos derivados de 4,8-difenilpoliazanaftaleno. |
| EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
| KR101156845B1 (ko) * | 2007-05-21 | 2012-06-18 | 에스지엑스 파마슈티컬스, 인코포레이티드 | 헤테로시클릭 키나제 조절제 |
| WO2009005675A1 (en) | 2007-06-28 | 2009-01-08 | Abbott Laboratories | Novel triazolopyridazines |
| EP2108641A1 (de) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | Neue substituierte Spiro[Cycloalkyl-1,3'-indo]-2'(1'H)-on-Derivate und ihre Verwendung als p38 mitogen-activated Kinase Inhibitoren |
| EP2113503A1 (de) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | Neue substituierte Indolin-2-on- Derivate und ihre Verwendung als p39 mitogen-activated Kinase Inhibitoren |
| EP2623101B1 (de) * | 2009-04-02 | 2021-04-21 | Merck Patent GmbH | Piperidin- und Piperazinderivate als Autotaxinhemmer |
| CA2778949C (en) | 2009-10-30 | 2018-02-27 | Janssen Pharmaceutica Nv | Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors |
| EP2322176A1 (de) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | Neue 7-Phenyl-[1,2,4]triazol[4,3-a]pyridin-3(2H)on-Derivate |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| TWI410425B (zh) | 2010-12-03 | 2013-10-01 | Lilly Co Eli | 唑并［５，４－ｂ］吡啶－５－基化合物 |
| BR112013033375B1 (pt) | 2011-06-27 | 2022-05-10 | Janssen Pharmaceutica N.V | Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário |
| CA2874303C (en) * | 2012-06-11 | 2020-10-13 | Ucb Biopharma Sprl | Tnf -alpha modulating benz imidazoles |
| RU2657540C2 (ru) | 2012-06-26 | 2018-06-14 | Янссен Фармацевтика Нв | Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств |
| EP2869822B1 (de) | 2012-07-09 | 2016-09-14 | Janssen Pharmaceutica, N.V. | Hemmer des phosphodiesterase-10-enzyms |
| GB201321738D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
| GB201321729D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321743D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| GB201321730D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| EP3221318B1 (de) * | 2014-11-21 | 2021-08-25 | Rigel Pharmaceuticals, Inc. | Kondensierte imidazolderivate als inhibitoren des transforming growth factor beta (tgf-beta) |
| PL3240785T3 (pl) | 2014-12-29 | 2021-12-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibitory drobnocząsteczkowe dehydrogenazy mleczanowej i sposoby ich wykorzystania |
| PE20171789A1 (es) | 2015-03-02 | 2017-12-28 | Bristol Myers Squibb Co | Inhibidores del factor beta de crecimiento de transformacion (tgf-beta) |
| WO2016160881A1 (en) * | 2015-04-01 | 2016-10-06 | Rigel Pharmaceuticals, Inc. | TGF-β INHIBITORS |
| US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
| WO2019071144A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| CN109467535B (zh) * | 2018-11-14 | 2022-07-12 | 江苏宝众宝达药业有限公司 | 一种芬苯达唑的制备方法 |
| CN119528787A (zh) * | 2023-08-31 | 2025-02-28 | 上海柏狮生物科技有限公司 | 以异腈和Michael受体制备一系列沃诺拉赞中间体的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| US6426360B1 (en) | 1994-07-28 | 2002-07-30 | G D Searle & Co. | 4,5-substituted imidazolyl compounds for the treatment of inflammation |
| IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
| US5717100A (en) | 1995-10-06 | 1998-02-10 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| TR199801361T2 (xx) | 1996-01-11 | 1998-10-21 | Smithkline Beecham Corporation | Yeni ikameli imidazol bile�imleri. |
| US6087496A (en) | 1998-05-22 | 2000-07-11 | G. D. Searle & Co. | Substituted pyrazoles suitable as p38 kinase inhibitors |
| US6335340B1 (en) | 1997-12-19 | 2002-01-01 | Smithkline Beecham Corporation | compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses |
| EP1112070B1 (de) * | 1998-08-20 | 2004-05-12 | Smithkline Beecham Corporation | Neue substituierte triazolverbindungen |
| JP2002541253A (ja) | 1999-04-09 | 2002-12-03 | スミスクライン・ビーチャム・コーポレイション | トリアリールイミダゾール |
| GB0007405D0 (en) | 2000-03-27 | 2000-05-17 | Smithkline Beecham Corp | Compounds |
| EP1370557B1 (de) | 2001-03-09 | 2005-11-16 | Pfizer Products Inc. | Entzündungshemmende benzimidazolverbindungen |
| GB0127430D0 (en) * | 2001-11-15 | 2002-01-09 | Smithkline Beecham Corp | Compounds |
-
2003
- 2003-07-31 AU AU2003256297A patent/AU2003256297A1/en not_active Abandoned
- 2003-07-31 US US10/522,227 patent/US7320995B2/en not_active Expired - Fee Related
- 2003-07-31 ES ES03784749T patent/ES2274302T3/es not_active Expired - Lifetime
- 2003-07-31 DE DE60309342T patent/DE60309342T2/de not_active Expired - Fee Related
- 2003-07-31 EP EP03784749A patent/EP1554272B1/de not_active Expired - Lifetime
- 2003-07-31 AT AT03784749T patent/ATE343572T1/de not_active IP Right Cessation
- 2003-07-31 WO PCT/US2003/019890 patent/WO2004014900A1/en not_active Ceased
- 2003-08-01 TW TW092121140A patent/TW200404799A/zh unknown
- 2003-08-01 AR AR20030102781A patent/AR040770A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60309342T2 (de) | 2007-05-16 |
| TW200404799A (en) | 2004-04-01 |
| AU2003256297A1 (en) | 2004-02-25 |
| US7320995B2 (en) | 2008-01-22 |
| EP1554272A1 (de) | 2005-07-20 |
| DE60309342D1 (de) | 2006-12-07 |
| ES2274302T3 (es) | 2007-05-16 |
| US20050272791A1 (en) | 2005-12-08 |
| WO2004014900A1 (en) | 2004-02-19 |
| EP1554272B1 (de) | 2006-10-25 |
| AR040770A1 (es) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60309342D1 (de) | Benzimidazole und benzothiazole als inhibitoren der map-kinase | |
| ATE447404T1 (de) | Substituierte benzazole und ihre verwendung als raf-kinase-hemmer | |
| CY2019012I2 (el) | Παραγωγα ν3 αλκυλιωμενου βενζιμιδαζολιου ως αναστολεις μεκ | |
| ATE526325T1 (de) | Substituierte benzimidazole als kinaseinhibitoren | |
| ATE423121T1 (de) | Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren | |
| ATE430754T1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
| ATE403654T1 (de) | Benzimidazol-, benzothiazol- und benzoxazolderivate und deren verwendung als lta4h-modulatoren | |
| IS7599A (is) | Heterósýklískir kínasatálmar | |
| ATE419849T1 (de) | Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren | |
| ATE416171T1 (de) | 2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren | |
| ATE410421T1 (de) | P38 inhibitor und anwendungsverfahren dafür | |
| DE60319430D1 (de) | R- und fgfr-inhibitoren | |
| ATE521604T1 (de) | N-substituierte benzimidazolyl-c-kit-inhibitoren und kombinatorische benzimidazolbibliothek | |
| DE60219068D1 (de) | Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren | |
| DE50313157D1 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
| DK1626964T3 (da) | Nye benzimidazolderivater | |
| ATE423117T1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone | |
| DE60322544D1 (de) | Glycinamid-derivate als raf-kinase-hemmer | |
| ATE308323T1 (de) | Diaminothiazole und ihre anwendung als cdk4 inhibitoren | |
| ATE435222T1 (de) | Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virus | |
| ATE382040T1 (de) | Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren | |
| DE602006017183D1 (de) | Benzimidazolderivat und anwendung davon | |
| ATE468338T1 (de) | Pyrrolochinolinderivate und ihre verwendung als proteinkinasehemmer | |
| ATE368654T1 (de) | Benzothiazol- und benzoxazol-4,7-dionderivate und ihre verwendung als cdc25-phosphatasen- inhibitoren | |
| ATE432703T1 (de) | Substituierte phenylacetamide und ihre anwendung als protease inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |